2/7/2013
ASHP, The Pew Charitable Trusts, and the American Hospital Association
brought together a group of stakeholders including top government officials,
practitioners, and nationally recognized experts in compounding and
manufacturing this week to discuss a wide range of issues surrounding sterile
compounding and to recommend solutions to improve patient safety.
The ASHP—Pew—AHA Pharmacy Sterile Compounding Summit explored the scope of pharmacy sterile compounding and the associated risk factors, the differences between sterile production expectations under Current Good Manufacturing Practices and United States Pharmacopeia Chapter 797, and oversight roles for states and the federal government.
Recommendations from the Summit will be publicized and made available on the ASHP Sterile Compounding Resource Center in coming weeks.
The ASHP—Pew—AHA Pharmacy Sterile Compounding Summit explored the scope of pharmacy sterile compounding and the associated risk factors, the differences between sterile production expectations under Current Good Manufacturing Practices and United States Pharmacopeia Chapter 797, and oversight roles for states and the federal government.
Recommendations from the Summit will be publicized and made available on the ASHP Sterile Compounding Resource Center in coming weeks.
Source found here
No comments:
Post a Comment